1Maiorca R,Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant, 1995,10(12) :2295 - 2305.
2Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada - USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol, 1996,7(2) : 198 - 207.
3Bargman JM, Thorpe KE, Churchill DN. for the CANUSA peritoneal dialysis study group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol, 2001, 12 (10) :2158 - 2162.
5Paniagua R,Amato D,Vonesh E,et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol, 2002,13(5) : 1307 - 1320.
6Termorshuizen F, Dekker FW, Manen JG, et al. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) - 2. J Am Soc Nephrol,2004,15(4) : 1061 - 1070.
7Stenvinkd P, Heimburger O, Lindholm B, et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationship between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant, 2000,15 (7):953 - 960.
8Wang AY, Woo J, Wang M, et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant, 2005,20 (2) : 396 - 403.
9Suda T, Hiroshige K, Ohta T, et al. The contribution of residual renal function to overall nutritional status in chronic heamodialysis patients. Nephrol Dial Transplant, 2000,15 (3):396 - 401.
10Chung SH, Heimburger O, Stenvinkel P, et al. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant,2003,18(3) :590 - 597.
9Launay-Vacher V, Lzzedine H, Mercadal L, et al. Clinical review: use of vancomycin in haemodialysis patients [J]. Crit Care,2002,6(4) :313.
10Iwamoto T, Kagawa Y, Kojima M.Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin[J]. Biol Pharm Bull, 2003,26 (6) : 876.
